Humacyte Inc (HUMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,833 | -148,701 | -110,776 | -11,965 | -26,477 |
| Depreciation Amortization | 7,345 | 7,190 | 8,201 | 9,756 | 9,218 |
| Accounts receivable | -261 | N/A | 31 | 145 | -63 |
| Accounts payable and accrued liabilities | 973 | -1,962 | 4,811 | -509 | -197 |
| Other Working Capital | -23,395 | 311 | 6,571 | 1,029 | -557 |
| Other Operating Activity | -48,871 | 45,040 | 17,857 | -69,585 | -63,114 |
| Operating Cash Flow | $-105,042 | $-98,122 | $-73,305 | $-71,129 | $-81,190 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 2,107 | 5,893 | -8,000 |
| PPE Investments | -884 | -1,572 | -2,280 | -1,048 | -220 |
| Investing Cash Flow | $-884 | $-1,572 | $-173 | $4,845 | $-8,220 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 39,783 | 20,000 | 39,377 | N/A | 29,659 |
| Debt Repayment | -2,754 | -2,579 | -33,756 | -1,981 | -1,729 |
| Common Stock Issued | 113,441 | 97,372 | 566 | 535 | 598 |
| Other Financing Activity | -88,984 | -610 | -1,680 | 0 | 238,455 |
| Financing Cash Flow | $61,486 | $114,183 | $4,507 | $-1,446 | $266,983 |
| Beginning Cash Position | 95,290 | 80,801 | 149,772 | 217,502 | 39,929 |
| End Cash Position | 50,850 | 95,290 | 80,801 | 149,772 | 217,502 |
| Net Cash Flow | $-44,440 | $14,489 | $-68,971 | $-67,730 | $177,573 |
| Free Cash Flow | |||||
| Operating Cash Flow | -105,042 | -98,122 | -73,305 | -71,129 | -81,190 |
| Capital Expenditure | -884 | -1,572 | -2,280 | -1,048 | -220 |
| Free Cash Flow | -105,926 | -99,694 | -75,585 | -72,177 | -81,410 |